Tweet from EricTopol at March 26, 2022 at 06:59PM
There are now 3 studies of the 4th vaccine (2nd booster) dose, all with short term follow-up
1. Good antibody response, safe, limited effectiveness vs symptomatic infections in health care professionals
https://t.co/WG7rsI5x9h https://t.co/yuIGe52JaL— Eric Topol (@EricTopol)
Mar 27, 2022
from http://twitter.com/EricTopol